BE902199A - Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide. - Google Patents

Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.

Info

Publication number
BE902199A
BE902199A BE0/214849A BE214849A BE902199A BE 902199 A BE902199 A BE 902199A BE 0/214849 A BE0/214849 A BE 0/214849A BE 214849 A BE214849 A BE 214849A BE 902199 A BE902199 A BE 902199A
Authority
BE
Belgium
Prior art keywords
carboxamide
triazole
medical treatment
viral diseases
ribofurannosyl
Prior art date
Application number
BE0/214849A
Other languages
English (en)
Inventor
R A Smith
H Fermandez
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE902199(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Publication of BE902199A publication Critical patent/BE902199A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

On utilise le composé 1-Beta-D-ribofurannosyl-1, 2, 4,-triazole-3-carboxamide seul ou en combinaison avec d'autres agents pharmacologiques dans le traitement médical de maladies virales chez l'etre humain, provoquées notamment par des virus syncytiaux respiratoires, des rétrovirus, des arénavirus ou des bunyavirus.
BE0/214849A 1984-10-29 1985-04-15 Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide. BE902199A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (1)

Publication Number Publication Date
BE902199A true BE902199A (fr) 1985-07-31

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214849A BE902199A (fr) 1984-10-29 1985-04-15 Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.

Country Status (18)

Country Link
EP (3) EP0383361A3 (fr)
JP (1) JPH0713019B2 (fr)
KR (1) KR860003018A (fr)
AT (1) ATE204173T1 (fr)
AU (1) AU584333B2 (fr)
BE (1) BE902199A (fr)
CA (1) CA1261265A (fr)
DD (1) DD261094A5 (fr)
DE (3) DE3588232T2 (fr)
ES (1) ES8704962A1 (fr)
FR (1) FR2572286B1 (fr)
GB (1) GB2166050B (fr)
LU (1) LU85854A1 (fr)
NL (1) NL300083I1 (fr)
NZ (1) NZ212510A (fr)
PH (1) PH22534A (fr)
PT (1) PT81387B (fr)
ZA (1) ZA858237B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003903A1 (fr) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulation de la replication, de l'infection et de la pathogenese retrovirales
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
CA2357735A1 (fr) * 1999-01-29 2000-08-03 Icn Pharmaceuticals, Inc. Modulation de reponse immunitaire par la ribavirine
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
WO2015197549A1 (fr) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi Ve Ticaret A.S. Nouvelle composition pharmaceutique de sofosbuvir et de ribavirine
EP2959901A1 (fr) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Combinaisons pharmaceutiques de sofosbuvir et ribavirine
EP2959891A1 (fr) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Compositions pharmaceutiques à libération modifiée de sofosbuvir et ribavirine
JP2018076280A (ja) * 2016-10-28 2018-05-17 国立大学法人 大分大学 ジカウイルス感染症治療用医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
WO1983003383A1 (fr) * 1982-03-29 1983-10-13 Liposome Co Inc Vesicules plurilamellaires stables

Also Published As

Publication number Publication date
DE181050T1 (de) 1986-12-18
PT81387B (pt) 1987-11-11
DE10299005I1 (de) 2002-05-08
NZ212510A (en) 1989-04-26
LU85854A1 (fr) 1985-12-16
EP0181050A3 (fr) 1987-10-21
DE3588232T2 (de) 2002-06-13
ZA858237B (en) 1988-02-24
ES8704962A1 (es) 1987-04-16
ES548303A0 (es) 1987-04-16
EP0383361A2 (fr) 1990-08-22
NL300083I1 (nl) 2002-05-01
EP0643970A3 (fr) 1997-07-09
GB2166050A (en) 1986-04-30
EP0643970B1 (fr) 2001-08-16
KR860003018A (ko) 1986-05-19
FR2572286A1 (fr) 1986-05-02
PT81387A (en) 1985-11-01
JPH0713019B2 (ja) 1995-02-15
FR2572286B1 (fr) 1990-03-23
HK1010985A1 (en) 1999-07-02
GB8509689D0 (en) 1985-05-22
EP0643970A2 (fr) 1995-03-22
EP0181050A2 (fr) 1986-05-14
EP0383361A3 (fr) 1993-06-16
JPS61109723A (ja) 1986-05-28
DE3588232D1 (de) 2001-09-20
CA1261265A (fr) 1989-09-26
DE10299005I2 (de) 2004-07-01
AU584333B2 (en) 1989-05-25
PH22534A (en) 1988-10-17
ATE204173T1 (de) 2001-09-15
AU4180785A (en) 1986-05-08
DD261094A5 (de) 1988-10-19
GB2166050B (en) 1989-08-16

Similar Documents

Publication Publication Date Title
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
MY130035A (en) Antiviral compounds
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3687069D1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
AU584333B2 (en) Method of medical treatment of human viral diseases utilizing 1-```-d-ribofuranosyl-1,2,4-triazole-3- carboxamide
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
ATE142499T1 (de) Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
EP0757697A4 (fr) Utilisation d'agents bloquant l'interaction molecule d'adhesion intercellulaire/recepteur dans le traitement d'une infection respiratoire virale
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
AU616657B2 (en) Butyl hydroxyanisoles for the treatment of retroviral diseases
DE69626276D1 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
FI821857A7 (fi) Amidoksiimien heterosykliset johdannaiset, niiden valmistus ja soveltaminen tautien hoitoon.
ES2072431T3 (es) D-acido aspartico beta-hidroxamato para el tratamiento de infecciones virales y de tumores.
ATE44801T1 (de) Vorrichtung zur behandlung von rauchgas, insbesondere auspuffgas.
FR2786099B1 (fr) Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу
DE3687895D1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.
ATE160782T1 (de) Fluoro-nukleosid-reinigung
DK0621785T3 (da) Anvendelse af vandige opløsninger indeholdende peroxobisulfationer til behandling af maligne celler
ATE36558T1 (de) Drehkoerper, vorrichtung und verfahren zur behandlung von metallschmelzen.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *VIRATEK INC.

Effective date: 20050415

RE20 Patent expired

Owner name: *VIRATEK INC.

Effective date: 20050415